Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)

NCT00813709 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Clinically Isolated Syndrome

Interventions

DRUG: RNF
DRUG: RNF
DRUG: RNF
DRUG: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany